Noninvasive Prognostic Biomarkers for Left-Sided Heart Failure as Predictors of Survival in Pulmonary Arterial Hypertension.

导出 OA

翻译打印收藏纠错

作者： Catherine E,Simpson ^[1] ; Rachel L,Damico ^[1] ; Paul M,Hassoun ^[1] ; Lisa J,Martin ^[2] ; Jun,Yang ^[3] ; Melanie K,Nies ^[3] ; R Dhananjay,Vaidya ^[4] ; Stephanie,Brandal ^[3] ; Michael W,Pauciulo ^[2] ; Eric D,Austin ^[5] ; D Dunbar,Ivy ^[6] ; William C,Nichols ^[2] ; Allen D,Everett ^[7]

作者单位： Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD. ^[1] Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH. ^[2] Division of Pediatric Cardiology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD. ^[3] Division of General Internal Medicine, Department of Medicine, Johns Hopkins University, Baltimore, MD. ^[4] Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Vanderbilt University, Nashville, TN. ^[5] Department of Pediatric Cardiology, Children's Hospital Colorado, Aurora, CO. ^[6] Division of Pediatric Cardiology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD. Electronic address: aeveret3@jhmi.edu. ^[7]

关键词 biomarkers heart failure molecular biology pulmonary hypertension